Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05535478 · ClinicalTrials.gov registry record · NA

Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's

A NA study, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
130
Enrollment target

NCT05535478 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 130 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05535478, a NA study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target

Study Summary

Objectives To 1) examine the ability of the STRIDE (Simplification of Treatment Regimens and Individualized Diabetes Education) educational program to increase deprescribing of high hypoglycemia risk glucose-lowering medications (HRMs) among long term care facility (LTCF) residents with ADRD, 2) assess key implementation constructs (secondary outcomes) of the STRIDE program, including acceptability, appropriateness, and feasibility, and 3) validate the primary HRM use outcome measure.

Interventions

  • BEHAVIORAL STRIDE

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2023-01-31
Est. Completion 2025-07-14
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT05535478

The ClinicalTrials.gov registry entry for NCT05535478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which STRIDE is the first listed.

NCT05535478 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05535478 about?

NCT05535478 is a clinical study titled "Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's". Objectives To 1) examine the ability of the STRIDE (Simplification of Treatment Regimens and Individualized Diabetes Education) educational program to increase deprescribing of high hypoglycemia risk glucose-lowering medications (HRMs) among long term care facility (LTCF) residents with ADRD, 2) ass...

What is the current status of trial NCT05535478?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2023-01-31. Estimated completion is 2025-07-14.

What interventions are being tested in trial NCT05535478?

The interventions under investigation include: STRIDE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05535478?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.